China Resources Shuanghe (600062.SH) announced that China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., a wholly-owned subsidiary of the company...
Zhitong Finance App News, China Resources Shuanghe (600062.SH) announced that China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. (“Shuanghe Limin”), a wholly-owned subsidiary of the company, has received the “Drug Registration Certificate” (certificate number: 2024S00857) for resorcinol injections issued by the China Drug Administration (“State Drug Administration”).
According to reports, resorcinol injections are used to treat acute spasmodic pain caused by digestive system and biliary tract dysfunction; acute spasmodic urethral, bladder, and renal colic; and gynecological spasmodic pain.